معرفی
Emilio Mottillo, PhD, holds the position of Associate Professor at Henry Ford Health Systems and Michigan State University (MSU), within the Department of Pharmacology & Toxicology, College of Human Medicine. He earned his PhD in Pathology from Wayne State University (2008-2013). His research focuses on lipid storage mechanisms in cells and their dysregulation in metabolic diseases, particularly cardiovascular and kidney diseases. His lab employs advanced techniques like real-time lipid imaging, super-resolution microscopy, and CRISPR-Cas9 genome editing to study lipid droplet protein interactions and cellular energy sensing.
Key research themes include understanding how lipid droplet surface proteins contribute to cardiometabolic diseases and identifying therapeutic targets. Current funding includes a NIH grant (2021-2026) investigating the ABHD5/PNPLA3 metabolon in lipid homeostasis. Employment history includes roles as Associate Professor at Wayne State University (2024), Associate Professor-Research at MSU (2023), and Associate Scientist at Henry Ford Hospital (2023).
His work spans molecular biology, cell biology, and animal physiology, with recent publications highlighting lipid-droplet targeting in liver disease and redox mechanisms in adipose tissue. His lab is located at the Integrative Biosciences Center in Detroit, emphasizing translational research for metabolic disease therapies.
